Calyxt, Inc. Stock Nasdaq
Stocks
CBUS
US17166A1016
Advanced Medical Equipment & Technology
| Market Cap | 122M 105M 98.35M 89.74M 168M 11.48B 168M 1.16B 450M 5.89B 456M 446M 18.75B | P/E 2026 * |
-1.1x | P/E 2027 * | -2.09x |
|---|---|---|---|---|---|
| Enterprise Value | 122M 105M 98.35M 89.74M 168M 11.48B 168M 1.16B 450M 5.89B 456M 446M 18.75B | EV / Sales 2026 * |
23.4x | EV / Sales 2027 * | 9.78x |
| Free-Float |
73.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Calyxt, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Wichner
CEO | Chief Executive Officer | 56 | 2026-06-07 |
Greg Gocal
CTO | Chief Tech/Sci/R&D Officer | 57 | 2013-12-31 |
Peter Beetham
CEO | Chief Executive Officer | 63 | 2025-02-23 |
| Director | Title | Age | Since |
|---|---|---|---|
Rory Riggs
CHM | Chairman | 72 | 2000-12-31 |
Peter Beetham
BRD | Director/Board Member | 63 | 2000-12-31 |
Mark Finn
CHM | Chairman | 82 | 2025-08-05 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 122M | |
| -0.75% | -1.35% | +24.60% | +14.36% | 227B | |
| -1.60% | -3.89% | +3.72% | -19.20% | 146B | |
| -0.85% | -1.58% | -21.45% | +19.12% | 130B | |
| +1.81% | +2.05% | -55.42% | -11.25% | 69.27B | |
| +0.13% | -0.34% | +11.07% | +16.81% | 51.82B | |
| -0.97% | -2.28% | -18.25% | -14.22% | 50.45B | |
| +0.59% | -1.94% | +17.17% | +27.91% | 42.53B | |
| -1.01% | -1.28% | +33.64% | +50.03% | 40.22B | |
| -1.55% | +1.22% | +120.58% | +36.40% | 32.95B | |
| Average | -0.42% | -0.94% | +12.85% | +13.33% | 87.75B | |
| Weighted average by Cap. | -0.63% | -1.41% | +6.61% | +8.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.19M 4.47M 4.2M 3.84M 7.18M 491M 7.2M 49.77M 19.24M 252M 19.51M 19.08M 801M | 12.43M 10.69M 10.06M 9.18M 17.17M 1.17B 17.22M 119M 46.05M 602M 46.68M 45.65M 1.92B |
| Net income | -66.51M -57.22M -53.83M -49.12M -91.88M -6.28B -92.15M -637M -246M -3.22B -250M -244M -10.26B | -61.4M -52.82M -49.69M -45.35M -84.82M -5.8B -85.07M -588M -227M -2.97B -231M -226M -9.47B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
